Epidemiological clinical characteristics in patients with type I cardiorenal syndrome
Keywords:
SÃNDROME CARDIORRENAL TIPO I, SÃNDROME CARDIORRENAL/epidemiologÃa, FACTORES DE RIESGO, LESIÓN RENAL AGUDA, INSUFICIENCIA CARDIACAAbstract
Introduction: cardiorenal syndrome is of recent knowledge worldwide and requires adequate medical action from the early stages. In a classification with five typologies, type I is the most frequent.
Objective: to describe the epidemiological clinical characteristics in patients with type I cardiorenal syndrome.
Methods: a cross-sectional descriptive observational study was carried out on the universe of 56 who were admitted to the cardiology ward of the Ciego de Ávila hospital between: April/2016-March/2018. A blood sample was taken to determine the parameters under study and a telecardiogram, electrocardiogram and echocardiogram was carried out. The information was obtained from the medical records. Ethical principles were met.
Results: predominance of the male sex (55,36 %), the age group 60 years and over (39,29 %), arterial hypertension as a risk factor and finding on physical examination (62.50 %), and decompensated chronic heart failure (51,79 %) as a type of acute heart failure. Left ventricular hypertrophy (51,79 %) was the main electrocardiographic change. The cardiothoracic index was normal in more than half (58,93 %) in the telecardiogram and diastolic dysfunction predominated (58,93 %) in the echocardiogram.
Conclusions: from the epidemiological point of view, it prevailed in men aged 60 years and over, and arterial hypertension was the most frequent risk factor. From the clinical point of view, decompensated chronic heart failure such as acute heart failure, arterial hypertension as a finding on cardiovascular physical examination, hypertrophy of the left ventricle as an electrocardiographic alteration and diastolic dysfunction as an echocardiographic one.Downloads
References
Preza PM, Hurtado A, Armas V, Cárcamo CP. Síndrome cardiorrenal tipo 1 en la unidad de cuidados intensivos coronarios del Hospital Nacional Arzobispo Loayza. Arch Cardiol Méx[Internet]. 2015[citado 12 Abr 2016]; 85(3): [aprox. 8 p.]. Disponible en: http://www.scielo.org.mx/scielo.php?pid=S1405-99402015000300002&script=sci_arttext
Iloyd Jones D, Adams R, Carnethon M, de Simone G, Ferguson T, Flegal k, et al. Heart Disease and Stroke Statistics 2009 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation.[Internet]. 2009[citado 12 Abr 2016]; 119: 480-6. Disponible en:http://circ.ahajournals.org/content/119/3/e21.full
Acle S, Ormaechea G, Álvarez P. Síndrome cardio-renal-anemia en la insuficiencia cardíaca sistólica .Arch MedInt [Internet]. 2014[citado 12 Abr 2016]; 36(3): [aprox. 8p.].Disponible en:http://www.scielo.edu.uy/scielo.php?pid=S1688423X2014000300001&script=sci_arttext&tlng=en
Bell Surís B, Ferrer I, Monteagudo A. Síndrome cardiorrenal. AMC [Internet]. Jun 2014[citado 14 Jul 2017]; 18(3): [aprox. 9 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1025-02552014000300009&script=sci_arttext
Pérez-Oliva J., Pérez R., Herrera R., Almaguer M., Brisquet E. (2017). Terapia renal de reemplazo dialítica durante los últimos 10 años. Rev Habanera Ciencias Médicas [serie en Internet] 11(3). Disponible en: http://www.bvs.sld.cu/revistas/rhab/vol_11_3_12/rhcm15312
Bodian M, Thiaw A, Sarr SA, Babaka K, Aw F, Ngaïde AA y otros. Syndrome cardio-rénal: aspects épidémiologiques, à propos de 36 cas dans un service de cardiologie de Dakar. Pan Afr Med J [Internet]. Sep 2017[citado 23 May 2018]; 28(58): [aprox. 11.p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718758/
Kazory A, Elkayam U. Cardiorenal interactions in acute decompensated heart failure: contemporary concepts facing emerging controversies. J Card Fail[Internet]. 2014[citado 15 Mar 2016]; 20(12):1004-11. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25230240
Haase M, Müller C, Damman K, Murray PT, Kellum JA, Ronco C, et al. Pathogenesis of Cardiorrenal Syndrome Type 1 in Acute Decompensated Heart Failure: Workgroup Statements from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol Basel Karger[Internet]. 2013[citado 24 May 2018]; 182: 99-116. Disponible en: https://www.karger.com/Article/FullText/349969
Casado J, Perez JI. Daño orgánico y síndrome cardiorrenal en la insuficiencia cardíaca aguda. Med Clin Barc[Internet]. Mar 2014[citado 24 May 2018]; 142(Suppl 1):26-31. Disponible en: https://www.sciencedirect.com/science/article/pii/S002577531470079X
Du Y, Li X, Liu B. Advances in pathogenesis and current therapeutic strategies for cardiorenal syndrome. Life Sci[Internet]. 2014[citado 24 Feb 2017]; 99:1-6. Disponible en: http://dx.doi.org/10.1016/j.lfs.2013.10.003
Ronco C, Haapio M, House AA. Cardiorenal syndrome. J Am Coll Cardiol[Internet]. 2014[citado 3 Abr 2018]; 52:1527-39. Disponible en: https://www.sciencedirect.com/sdfe/pdf/download/eid/1-s2.0-S1551713613001608/first-page-pdf
Mora Dávila S, Dávila Zea D, Silva Nani E, Mesquita Tinoco E, Martins de Andrade W, Villacorta Humberto J. Síndrome cardio-renal tipo 1: Mecanismos fisiopatológicos y papel de los nuevos biomarcadores. Insuf Card [Internet]. Ene 2016[citado 24 May 2018]; 11(1):55-62. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1852-38622016000100006&lng=es
Ferri FF. Cardiorenal Syndrome. Ferri´s Clinical Advisor[Internet].2016[citado 30 Abr 2016]: 291-292.e1. Disponible en: https://www.clinicalkey
.es/#!/content/book/3-s2.0-B9780323280471001505
Haase M, Müller C, Damman K, Murray PT, Kellum JA, Ronco C, et al. Pathogenesis of Cardiorenal Syndrome Type 1 in Acute Decompensated Heart Failure: Workgroup Statements from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol Basel Karger [Internet]. 2013[citado 24 May 2018]; 182: 99-116. Disponible en: https://www.karger.com/Article/FullText/349969
Lobo Márquez LL. Nuevos paradigmas sobre "temas congestivos" en insuficiencia cardíaca aguda. Insuf Card [Internet]. 2009[citado 12 Abr 2016]; 4(3): [aprox. 7 p.]. Disponible en:http://www.scielo.org.ar/scielo.php?pid=S185238622009000300007&script=sci_arttext&tlng=en
Mora Dávila S, Dávila Zea D, Silva Nani E, Mesquita Tinoco E, Martins de Andrade W, Villacorta Humberto J. Síndrome cardio-renal tipo 1: Mecanismos fisiopatológicos y papel de los nuevos biomarcadores. Insuf Card [Internet]. Ene 2016[citado 24 May 2018]; 11(1):55-62. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1852-38622016000100006&lng=es
Montenegro AC, Silva LE, Muñoz MA. Síndrome cardio-renal anémico. Acta Med Colomb [Internet]. Sep 2011 [citado 31 Jul 2018]; 36(3): 141-144. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-24482011000300006&lng=en
Campañá Cobas NG, Carballés García F, Florín Irabién J, Betancourt Pérez AA, Campañá Cobas EE, Durán Casal D. Alteraciones cardiovasculares en pacientes en hemodiálisis. Rev Cubana Pediatr [Internet]. Dic 2003 [citado 01 Ago 2018]; 75(4): [aprox. 9 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312003000400001&lng=es
De Assis Costa F, Romero Rivera I, Castro de Vasconcelos ML, Falcão Pedrosa Costa A, Dos Santos Póvoa RM, Nogueira Bombig Mt, et al. El electrocardiograma en el diagnóstico de la hipertrofia ventricular de pacientes con enfermedad renal crónica. Arq Bras Cardiol [Internet]. Oct 2009 [citado 24 Mar 2017]; 93(4): [aprox. 15 p.]. Disponible en: http://www.scielo.br/scielo.php?pid=S0066-782X2009001000011&script=sci_arttext&tlng=es
López J M, Jofré R, Verde E. Complicaciones cardiovasculares en el enfermo en Hemodiálisis. En: Jofré R, López Gomes JM, Luño J, Pérez García R, Rodríguez Benítez P, editores. Tratado de Hemodiálisis. 2da ed. Barcelona: Médica JIMS; 2013.
Álvarez González Y, Bohorquez Rodríguez R, Vega Pedraza D, Noa Fernández L. Alteraciones cardiovasculares de pacientes en un programa de diálisis peritoneal domiciliaria. Instituto de Nefrología, Cuba. Rev Cubana Cardiol Cir Cardiovas[Internet].2017[citado 6 Abr 2018]; 23(4): 479-488.Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/702/html_100
Ronco C, Cicoira M, McCullough PA. Cardiorenal SyndromeType 1. JACC [Internet].2012 [citado 12 mar 2016]; 60(12): 1031-1042. Disponible en: https://www.clinicalkey.es/#!/content/journal/1-s2.0-S0735109712019559
Mavrakanas T, Khattak A, Singh K, Charytan D. Epidemiology and Natural History of the Cardiorenal Syndromes in a Cohort with Echocardiography. Clin J Am Soc Nephrol [Internet]. 2017 [citado 24 May 2018]; 12(10): 16247-1633. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28801528
Published
How to Cite
Issue
Section
License
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The journal is not responsible for the opinions and concepts expressed in the works, which are the exclusive responsibility of the authors. The Editor, with the assistance of the Editorial Committee, reserves the right to suggest or request advisable or necessary modifications. Original scientific works are accepted for publication, as are the results of research of interest that have not been published or sent to another journal for the same purpose.
The mention of trademarks of specific equipment, instruments or materials is for identification purposes, and there is no promotional commitment in relation to them, neither by the authors nor by the editor.
